Lataa...

维吾尔族肺腺癌患者的EGFR基因突变分析

BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor (EGFR), a transmembrane protein, is a member of the tyrosine kinase family. Gefitinib, an EGFR tyrosine-kinase inhibitors, has shown a high response rate in the treatment of lung cancer in patients with EGFR mutation. However, significant di...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Zhongguo Fei Ai Za Zhi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 中国肺癌杂志编辑部 2013
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6000386/
https://ncbi.nlm.nih.gov/pubmed/23425899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2013.02.04
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!